back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-03-29 16:17 Tx date 2022-03-29 |
$RVX
Resverlogix Corp. |
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-2,239,897 vol |
0 | |
| Filed 2022-02-03 21:52 Tx date 2021-08-14 |
$RVX
Resverlogix Corp. |
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
3 - 10% Security Holder of Issuer
Holder: Hepalink (Hong Kong) Limited (Indirect Ownership)
|
Warrants
55 - Expiration of warrants
|
-1,786,667 vol |
300,000 | |
| Filed 2022-02-03 01:43 Tx date 2022-01-31 |
$RVX
Resverlogix Corp. |
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-1,106,699 vol |
2,239,897 | |
| Filed 2022-02-03 01:42 Tx date 2021-12-01 |
$RVX
Resverlogix Corp. |
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-5,000,023 vol |
3,346,596 | |
| Filed 2022-02-03 01:40 Tx date 2021-06-20 |
$RVX
Resverlogix Corp. |
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-1,333,333 vol |
8,346,619 | |
| Filed 2021-05-14 18:18 Tx date 2021-05-13 |
$RVX
Resverlogix Corp. |
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
3 - 10% Security Holder of Issuer
Holder: Hepalink (Hong Kong) Limited (Indirect Ownership)
|
Warrants
53 - Grant of warrants
|
+300,000 vol |
2,086,667 | |
| Filed 2021-05-14 18:16 Tx date 2021-05-13 |
$RVX
Resverlogix Corp. |
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
3 - 10% Security Holder of Issuer
Holder: Hepalink (Hong Kong) Limited (Indirect Ownership)
|
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption
|
+$6,000,000 vol |
$6,000,000 | |
| Filed 2021-05-14 18:14 Tx date 2015-07-20 |
$RVX
Resverlogix Corp. |
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
3 - 10% Security Holder of Issuer
Holder: Hepalink (Hong Kong) Limited (Indirect Ownership)
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-08-19 12:15 Tx date 2020-07-20 |
$RVX
Resverlogix Corp. |
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-1,000,000 vol |
9,679,952 | |
| Filed 2020-08-17 16:29 Tx date 2020-08-14 |
$RVX
Resverlogix Corp. |
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
3 - 10% Security Holder of Issuer
Holder: Hepalink (Hong Kong) Limited (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+1,786,667 vol |
1,786,667 | |
| Filed 2020-08-17 16:28 Tx date 2015-07-20 |
$RVX
Resverlogix Corp. |
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
3 - 10% Security Holder of Issuer
Holder: Hepalink (Hong Kong) Limited (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-08-17 16:27 Tx date 2020-08-14 |
$RVX
Resverlogix Corp. |
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
3 - 10% Security Holder of Issuer
Holder: Hepalink (Hong Kong) Limited (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$2,679,999
+3,573,333 vol $0.75 each |
3,573,333 | |
| Filed 2020-08-17 16:26 Tx date 2015-07-20 |
$RVX
Resverlogix Corp. |
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
3 - 10% Security Holder of Issuer
Holder: Hepalink (Hong Kong) Limited (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|